ARCHIVES

NCI-Approved CTEP Trials For the Month of December

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002

Tom King To Leave NCI For Kennedy Ethics Institute; Cal Baldwin To Take NIH Job

June 27, 1980

NIH To Give 3 Percent Increase to Grants

March 20, 2009

Ad Hoc Internet Group Send Rebuttal To Scher’s Letter.

April 27, 2007

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

Nexavar Improves PFS In Phase III Trial

January 25, 2013